Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A TEICHER

Showing results (21-30 of 372) with videos related to

Pageof 38
Sort By:
Biochemical Pharmacology|October 5, 2013
Targets in small cell lung cancerBeverly A Teicher
Cancer Metastasis Reviews|June 1, 1994
Hypoxia and drug resistanceB A Teicher
Current Cancer Drug Targets|December 23, 2009
Antibody-drug conjugate targetsB A Teicher
Toxicologic Pathology|December 23, 2008
In vivo/ex vivo and in situ assays used in cancer research: a brief reviewBeverly A Teicher
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Transforming growth factor-beta and the immune response to malignant diseaseBeverly A Teicher
Current Pharmaceutical Design|July 27, 2001
Cryptophycins: a novel class of potent antimitotic antitumor depsipeptidesC Shih, B A Teicher
Investigational New Drugs|January 1, 1997
Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agentsY Kakeji, B A Teicher
Cancer Chemotherapy and Pharmacology|January 1, 1988
Development of alkylating agent-resistant human tumor cell linesB A Teicher, E Frei
Biochemical Pharmacology|April 20, 2006
TGF-beta in cancer and as a therapeutic targetJan Pinkas, Beverly A Teicher
Current Cancer Drug Targets|February 25, 2022
Antibody-drug Conjugate Targets, Drugs, and LinkersBeverly A Teicher, Joel Morris
Pageof 38

Showing results (21-30 of 372) with videos related to

Sort By:
Pageof 38
Biochemical Pharmacology|October 5, 2013
Targets in small cell lung cancerBeverly A Teicher
Cancer Metastasis Reviews|June 1, 1994
Hypoxia and drug resistanceB A Teicher
Current Cancer Drug Targets|December 23, 2009
Antibody-drug conjugate targetsB A Teicher
Toxicologic Pathology|December 23, 2008
In vivo/ex vivo and in situ assays used in cancer research: a brief reviewBeverly A Teicher
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Transforming growth factor-beta and the immune response to malignant diseaseBeverly A Teicher
Current Pharmaceutical Design|July 27, 2001
Cryptophycins: a novel class of potent antimitotic antitumor depsipeptidesC Shih, B A Teicher
Investigational New Drugs|January 1, 1997
Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agentsY Kakeji, B A Teicher
Cancer Chemotherapy and Pharmacology|January 1, 1988
Development of alkylating agent-resistant human tumor cell linesB A Teicher, E Frei
Biochemical Pharmacology|April 20, 2006
TGF-beta in cancer and as a therapeutic targetJan Pinkas, Beverly A Teicher
Current Cancer Drug Targets|February 25, 2022
Antibody-drug Conjugate Targets, Drugs, and LinkersBeverly A Teicher, Joel Morris
Pageof 38